title: [Consideration of cancer home chemotherapy with cooperation between hospital and clinic].
abstract: Recently, the progress in chemotherapy has brought an improvement in the survival rate of patients with non-resectable digestive tract cancer. Simultaneously, maintenance of patients' QOL is regarded as important. In our hospital, we use low-dose FP therapy to maintain QOL and a satisfactory survival rate. To date, we have administered low-dose FP to more than 50 patients with non-resectable digestive cancer. We investigated patients who received home chemotherapy after being evaluated NC, and found no remarkable side effects as a result of this therapy during admission.
authors.affiliation: Dept. of Gastroenterology, Jizankai Medical Foundation, Tsuboi Cancer Center Hospital.
authors.forename: Y
authors.initials: Y
authors.lastname: Muto
authors.forename: K
authors.initials: K
authors.lastname: Takebuchi
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Hasegawa
authors.forename: M
authors.initials: M
authors.lastname: Sakonji
authors.forename: M
authors.initials: M
authors.lastname: Matsukawa
authors.forename: M
authors.initials: M
authors.lastname: Kurihara
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003299:Cooperative Behavior; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D018575:Home Care Services, Hospital-Based; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D005641:Tegafur; D014498:Uracil; D002945:Cisplatin; D005472:Fluorouracil